Onsdag 12 Mars | 11:53:46 Europe / Stockholm

Kalender

Est. tid*
2025-11-21 08:20 Kvartalsrapport 2025-Q3
2025-08-21 08:20 Kvartalsrapport 2025-Q2
2025-05-22 N/A X-dag ordinarie utdelning RAYTL 0.00 SEK
2025-05-21 N/A Årsstämma
2025-05-21 08:20 Kvartalsrapport 2025-Q1
2025-02-20 - Bokslutskommuniké 2024
2024-12-16 - Extra Bolagsstämma 2025
2024-10-30 - Kvartalsrapport 2024-Q3
2024-09-27 - Extra Bolagsstämma 2024
2024-08-22 - Kvartalsrapport 2024-Q2
2024-06-14 - X-dag ordinarie utdelning RAYTL 0.00 SEK
2024-06-13 - Årsstämma
2024-05-28 - Split RAYTL 100:1
2024-05-23 - Kvartalsrapport 2024-Q1
2024-02-23 - Bokslutskommuniké 2023
2023-11-24 - Extra Bolagsstämma 2023
2023-11-23 - Kvartalsrapport 2023-Q3
2023-08-24 - Kvartalsrapport 2023-Q2
2023-05-25 - Kvartalsrapport 2023-Q1
2023-05-03 - X-dag ordinarie utdelning RAYTL 0.00 SEK
2023-05-02 - Årsstämma
2023-02-28 - Bokslutskommuniké 2022
2022-11-30 - Kvartalsrapport 2022-Q3
2022-10-07 - Extra Bolagsstämma 2022
2022-08-26 - Kvartalsrapport 2022-Q2
2022-05-13 - Kvartalsrapport 2022-Q1
2022-04-19 - X-dag ordinarie utdelning RAYTL 0.00 SEK
2022-04-18 - Årsstämma
2022-02-25 - Bokslutskommuniké 2021
2021-11-26 - Kvartalsrapport 2021-Q3
2021-08-27 - Kvartalsrapport 2021-Q2
2021-05-27 - Kvartalsrapport 2021-Q1
2021-04-20 - X-dag ordinarie utdelning RAYTL 0.00 SEK
2021-04-19 - Årsstämma
2021-02-26 - Bokslutskommuniké 2020
2020-11-27 - Kvartalsrapport 2020-Q3
2020-10-20 - Extra Bolagsstämma 2020
2020-08-27 - Kvartalsrapport 2020-Q2
2020-05-27 - Kvartalsrapport 2020-Q1
2020-04-21 - X-dag ordinarie utdelning RAYTL 0.00 SEK
2020-04-20 - Årsstämma
2020-02-27 - Bokslutskommuniké 2019
2019-10-21 - Kvartalsrapport 2019-Q3
2019-04-23 - X-dag ordinarie utdelning RAYTL 0.00 SEK
2019-04-18 - Årsstämma
2019-02-19 - Bokslutskommuniké 2018

Beskrivning

LandSverige
ListaNordic SME Sweden
SektorHälsovård
IndustriMedicinteknik
Raytelligence är ett investeringsbolag. Bolagets nyckelstrategi är att identifiera och slutföra en kombination med en verksamhet inom någon av följande sektorer fordonsindustri, finansiella tjänster, livsmedelsteknik, hälsovård, spjutspetsteknologi och mediasektorer, även om företaget förbehåller sig rätten att utöva en förvärvsmöjlighet i alla företag eller branscher. Verksamheten bedrivs i Europa och Asien, och huvudkontoret ligger i Stockholm.
2025-01-09 08:15:00

Raytelligence's assignment from Stemtech Corporation continues. The assignment includes advice on a reverse takeover of Stemtech Corporation by a company traded on a Nordic marketplace.

On 12 December, the Board of Directors of Spotlight-traded Eevia Health Plc announced that it had decided to terminate the process of a reverse takeover of Stemtech. Raytelligence acted as advisor in this process. Raytelligence's assignment continues and is focused on identifying other possible candidates.

Stemtech Corporation and Seacret Direct, LLC (renamed `VIÁGO') reached an agreement on 20 November 2024 on a strategic merger. In connection with this agreement, Raytelligence announced that it had received an assignment from Stemtech regarding advice in connection with the reverse acquisition of a company whose shares are traded on a marketplace in the Nordic region.

Raytelligence's remuneration is mainly paid in shares in the event of a successfully completed transaction and in the event that the transaction is not completed, no consulting fee is paid.

Driving innovation and market expansion:

Stemtech Corporation: Stemtech and VIÁGO offer a strong combination of stem cell-based supplements and a diverse customer offering in lifestyle and wellness that includes travel, health, beauty and events. The company has over 250,000 members, customers and independent representatives and operates in over 40 countries, in North and South America, Asia, Africa and Europe..

For further information, please contact:

Ben Hedenberg, CFO, Raytelligence AB

E-mail: ben.hedenberg@raytelligence.com

Phone: +46 (0)8-551 160 90 / +44 7944 316 906

Briefly about Raytelligence

Raytelligence is an investment company whose key strategy is to identify and complete combination deals with businesses in any of the following sectors biotechnology & pharmaceuticals, automotive, financial services, communications technology, food technology, cutting edge technologies and media sectors in Europe, America and Asia that can benefit from our management team's extensive experience and operational capability, although the company reserves the right to exercise an acquisition option in any company or industry. Raytelligence is listed on NGM Nordic SME.